Fusion gene mutations as biomarkers of pancreatic cancer lymph node metastases

融合基因突变作为胰腺癌淋巴结转移的生物标志物

• 批准号: 7938340
• 负责人: Nicole R Murray
• 金额: $ 20.23万
• 依托单位: MAYO CLINIC JACKSONVILLE
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-07-01 至 2012-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7938340
• 关键词: Biological Assay; Biological Markers; Biopsy; Breast Cancer Cell; Cancer Patient; Cancer cell line; Candidate Disease Gene; Cells; Cessation of life; Clinical; Cloning; Costs and Benefits; Counseling; DNA Sequence; DNA Sequence Rearrangement; Data; Detection; Development; Diagnosis; Diagnostic; Dideoxy Chain Termination DNA Sequencing; Disease; Disease-Free Survival; Distant; Event; Excision; Exhibits; Fine needle aspiration biopsy; Formalin; Freezing; Funding; Gene Fusion; Gene Mutation; Generations; Genes; Genome; Goals; Histologic; Laboratories; Malignant Neoplasms; Malignant neoplasm of pancreas; Messenger RNA; Metastatic Neoplasm to Lymph Nodes; Micrometastasis; Morbidity - disease rate; Mutation; Neoplasm Metastasis; Oncogenes; Operative Surgical Procedures; Pancreas; Paraffin Embedding; Patients; Pilot Projects; Positive Lymph Node; Prevalence; Primary Neoplasm; Probability; Procedures; Process; Proteins; Protocols documentation; RNA Sequences; Reagent; Relative (related person); Relative Risks; Resources; Risk; Sampling; Sensitivity and Specificity; Sequence Alignment; Sequence Analysis; Surgeon; Techniques; Technology; Testing; Time; Tissues; Transcript; Ultrasonography; cancer cell; cancer type; chronic pancreatitis; clinical material; cohort; design; effective therapy; experience; fusion gene; gene repair; high risk; insertion/deletion mutation; lymph nodes; minimally invasive; molecular marker; mortality; neoplastic cell; next generation; novel; pancreatic neoplasm; repaired; research study; success; tumor